If You Invested $1,000 in Novavax in January, This Is How Much Money You'd Have Now
Novavax (NASDAQ: NVAX) represents the dream investment. At the beginning of the year, you invest in an interesting clinical-stage biotech trading at less than $5 a share. Then, in a matter of months, positive investigational product news drives its stock price up. And by the end of the year, it's the best performer in the entire market.
Novavax started 2020 at $3.98 a share. From there, it soared more than 2,700% on optimism about its potential coronavirus vaccine as well as the promise of its flu vaccine candidate. So, how much would you have now if you had invested $1,000 in Novavax in January? Let's do the math.
Source Fool.com